In accordance with a previous study that p16INK4a expressed in various organs and tissues, such as the brain, liver, and spleen, but not in the muscle, during aging (Idda et al., 2020), while senescent cells may be the therapeutic target of cardiovascular diseases (Childs et al., 2018). Here, CDKN2A is linked to cardiovascular disorder.